# KKR Real Estate Finance Trust Inc.: financial statements, quarterly

KREF · NYSE · CIK 1631596 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kref.md) · [Financials](/companies/kref/financials.md) · [Filings](/companies/kref/filings.md) · [Insiders](/companies/kref/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kref/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [119](/filings/0001631596-24-000008.md) | [119](/filings/0001631596-24-000008.md) | [112](/filings/0001631596-24-000017.md) | [109](/filings/0001631596-24-000028.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.2](/filings/0001631596-25-000012.md) | [0.2](/filings/0001631596-25-000012.md) | [0.0](/filings/0001628280-26-005092.md) | [0.1](/filings/0001628280-26-005092.md) | [0.1](/filings/0001628280-26-005092.md) | [0.0](/filings/0001628280-26-005092.md) | [0.0](/filings/0001628280-26-026591.md) | [0.0](/filings/0001628280-26-049028.md) | [0.0](/filings/0001628280-26-005092.md) | [(0.2)](/filings/0001628280-26-005092.md) | [0.0](/filings/0001628280-26-026591.md) | [0.0](/filings/0001628280-26-049028.md) |
| Net income | $m | [27.1](/filings/0001631596-25-000012.md) | [(12.9)](/filings/0001631596-25-000012.md) | [(3.1)](/filings/0001628280-26-005092.md) | [25.8](/filings/0001628280-26-005092.md) | [(7.4)](/filings/0001628280-26-005092.md) | [20.3](/filings/0001628280-26-005092.md) | [(4.9)](/filings/0001628280-26-026591.md) | [(29.7)](/filings/0001628280-26-049028.md) | [13.8](/filings/0001628280-26-005092.md) | [(26.2)](/filings/0001628280-26-005092.md) | [(56.1)](/filings/0001628280-26-026591.md) | [(116)](/filings/0001628280-26-049028.md) |
| Diluted EPS | $ per share | [0.31](/filings/0001631596-25-000012.md) | [(0.27)](/filings/0001631596-25-000012.md) | [(0.13)](/filings/0001628280-26-005092.md) | [0.29](/filings/0001628280-26-005092.md) | [(0.19)](/filings/0001628280-26-005092.md) | [0.21](/filings/0001628280-26-005092.md) | [(0.15)](/filings/0001628280-26-026591.md) | [(0.53)](/filings/0001628280-26-049028.md) | [0.12](/filings/0001628280-26-005092.md) | [(0.49)](/filings/0001628280-26-005092.md) | [(0.96)](/filings/0001628280-26-026591.md) | [(1.95)](/filings/0001628280-26-049028.md) |
| Basic EPS | $ per share | [0.31](/filings/0001631596-25-000012.md) | [(0.27)](/filings/0001631596-25-000012.md) | [(0.13)](/filings/0001628280-26-005092.md) | [0.29](/filings/0001628280-26-005092.md) | [(0.19)](/filings/0001628280-26-005092.md) | [0.21](/filings/0001628280-26-005092.md) | [(0.15)](/filings/0001628280-26-026591.md) | [(0.53)](/filings/0001628280-26-049028.md) | [0.12](/filings/0001628280-26-005092.md) | [(0.49)](/filings/0001628280-26-005092.md) | [(0.96)](/filings/0001628280-26-026591.md) | [(1.95)](/filings/0001628280-26-049028.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [108](/filings/0001631596-24-000039.md) | [136](/filings/0001628280-26-005092.md) | [107](/filings/0001631596-25-000029.md) | [107](/filings/0001631596-25-000041.md) | [109](/filings/0001628280-25-045722.md) | [105](/filings/0001628280-26-005092.md) | [106](/filings/0001628280-26-026591.md) | [108](/filings/0001628280-26-049028.md) | [204](/filings/0001628280-25-045722.md) | [84.6](/filings/0001628280-26-049028.md) | [135](/filings/0001628280-26-026591.md) | [83.1](/filings/0001628280-26-049028.md) |
| Total assets | $m | [7,625](/filings/0001631596-23-000043.md) | [7,548](/filings/0001631596-25-000012.md) | [7,257](/filings/0001631596-24-000017.md) | [7,064](/filings/0001631596-24-000028.md) | [6,774](/filings/0001631596-24-000039.md) | [6,350](/filings/0001628280-26-005092.md) | [6,555](/filings/0001631596-25-000029.md) | [6,755](/filings/0001631596-25-000041.md) | [6,485](/filings/0001628280-25-045722.md) | [6,465](/filings/0001628280-26-049028.md) | [6,950](/filings/0001628280-26-026591.md) | [6,559](/filings/0001628280-26-049028.md) |
| Total liabilities | $m | [6,172](/filings/0001631596-23-000043.md) | [6,143](/filings/0001631596-25-000012.md) | [5,877](/filings/0001631596-24-000017.md) | [5,625](/filings/0001631596-24-000028.md) | [5,363](/filings/0001631596-24-000039.md) | [4,952](/filings/0001628280-26-005092.md) | [5,191](/filings/0001631596-25-000029.md) | [5,462](/filings/0001631596-25-000041.md) | [5,203](/filings/0001628280-25-045722.md) | [5,239](/filings/0001628280-26-049028.md) | [5,797](/filings/0001628280-26-026591.md) | [5,569](/filings/0001628280-26-049028.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,454](/filings/0001631596-23-000043.md) | [1,405](/filings/0001631596-25-000012.md) | [1,381](/filings/0001631596-24-000017.md) | [1,386](/filings/0001631596-24-000028.md) | [1,358](/filings/0001631596-24-000039.md) | [1,345](/filings/0001628280-26-005092.md) | [1,310](/filings/0001631596-25-000029.md) | [1,240](/filings/0001631596-25-000041.md) | [1,230](/filings/0001628280-25-045722.md) | [1,173](/filings/0001628280-26-049028.md) | [1,096](/filings/0001628280-26-026591.md) | [932](/filings/0001628280-26-049028.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [41.8 d](/filings/0001631596-24-000039.md) | [36.8 d](/filings/0001628280-26-005092.md) | [34.5](/filings/0001631596-25-000029.md) | [30.6 d](/filings/0001631596-25-000041.md) | [49.1 d](/filings/0001628280-25-045722.md) | [18.3 d](/filings/0001628280-26-005092.md) | [15.9](/filings/0001628280-26-026591.md) | [21.1 d](/filings/0001628280-26-049028.md) | [18.5 d](/filings/0001628280-25-045722.md) | [16.7 d](/filings/0001628280-26-005092.md) | [13.1](/filings/0001628280-26-026591.md) | [14.6 d](/filings/0001628280-26-049028.md) |
| Dividends paid | $m | [29.7 d](/filings/0001631596-24-000039.md) | [29.7 d](/filings/0001628280-26-005092.md) | [29.8](/filings/0001631596-25-000029.md) | [17.3 d](/filings/0001631596-25-000041.md) | [17.3 d](/filings/0001628280-25-045722.md) | [17.3 d](/filings/0001628280-26-005092.md) | [17.2](/filings/0001628280-26-026591.md) | [17.0 d](/filings/0001628280-26-049028.md) | [16.4 d](/filings/0001628280-25-045722.md) | [16.3 d](/filings/0001628280-26-005092.md) | [16.1](/filings/0001628280-26-026591.md) | [16.1 d](/filings/0001628280-26-049028.md) |
| Share repurchases | $m | [0.0 d](/filings/0001631596-23-000043.md) | [0.0 d](/filings/0001628280-26-005092.md) | [0.0](/filings/0001631596-25-000029.md) | [0.0 d](/filings/0001631596-25-000041.md) | [0.0 d](/filings/0001628280-25-045722.md) | [10.0 d](/filings/0001628280-26-005092.md) | [9.8](/filings/0001628280-26-026591.md) | [20.1 d](/filings/0001628280-26-049028.md) | [4.2 d](/filings/0001628280-25-045722.md) | [9.3 d](/filings/0001628280-26-005092.md) | [0.8](/filings/0001628280-26-026591.md) | [38.1 d](/filings/0001628280-26-049028.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [69.1](/filings/0001631596-25-000012.md) | [69.4](/filings/0001631596-25-000012.md) | [69.4](/filings/0001628280-26-005092.md) | [69.4](/filings/0001628280-26-005092.md) | [69.4](/filings/0001628280-26-005092.md) | [69.3](/filings/0001628280-26-005092.md) | [68.8](/filings/0001628280-26-026591.md) | [67.2](/filings/0001628280-26-049028.md) | [65.9](/filings/0001628280-26-005092.md) | [65.4](/filings/0001628280-26-005092.md) | [64.7](/filings/0001628280-26-026591.md) | [62.5](/filings/0001628280-26-049028.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 58,577,948 at 2026-07-20, from the cover of the [10-Q filed 2026-07-21](/filings/0001628280-26-049028.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.